Literature DB >> 15059901

GW112, a novel antiapoptotic protein that promotes tumor growth.

Xiuwu Zhang1, Qian Huang, Zhonghui Yang, Yongping Li, Chuan-Yuan Li.   

Abstract

GW112 is a novel gene that has little homology to other known genes. It is overexpressed in a number of human tumor types, especially in those of the digestive system. We show here that GW112 is associated with GRIM-19, a protein known to be involved in regulating cellular apoptosis. Functionally, GW112 could significantly attenuate the ability of GRIM19 to mediate retinoic acid-IFN-beta-mediated cellular apoptosis and apoptosis-related gene expression. In addition, GW112 demonstrated strong antiapoptotic effects in tumor cells treated with other stress exposures such as hydrogen peroxide. Finally, forced overexpression of GW112 in murine prostate tumor cells led to more rapid tumor formation in a syngeneic host. Taken together, our data suggest that GW112 is an important regulator of cell death that plays important roles in tumor cell survival and tumor growth.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15059901     DOI: 10.1158/0008-5472.can-03-3443

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  53 in total

1.  Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells.

Authors:  Kelli L VanDussen; Alexis J Carulli; Theresa M Keeley; Sanjeevkumar R Patel; Brent J Puthoff; Scott T Magness; Ivy T Tran; Ivan Maillard; Christian Siebel; Åsa Kolterud; Ann S Grosse; Deborah L Gumucio; Stephen A Ernst; Yu-Hwai Tsai; Peter J Dempsey; Linda C Samuelson
Journal:  Development       Date:  2011-12-21       Impact factor: 6.868

2.  Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-2'-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis.

Authors:  Wenli Liu; Hyun Woo Lee; Yueqin Liu; Ruihong Wang; Griffin P Rodgers
Journal:  Blood       Date:  2010-08-19       Impact factor: 22.113

3.  Construction of recombinant adenovirus carrying GRIM19 and its effect on SW480 cells.

Authors:  Shen Wang; Guihua Wang; Yu Deng; Xuelai Luo; Xiaolan Li; Deding Tao; Jianping Gong; Junbo Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-02

4.  Olfactomedin-4 regulation by estrogen in the human endometrium requires epidermal growth factor signaling.

Authors:  Hellen Dassen; Chamindie Punyadeera; Bert Delvoux; Iris Schulkens; Claudia Marchetti; Rick Kamps; Jan Klomp; Fred Dijcks; Anton de Goeij; Thomas D'Hooghe; Cleophas Kyama; Antwan Ederveen; Gerard Dunselman; Patrick Groothuis; Andrea Romano
Journal:  Am J Pathol       Date:  2010-11       Impact factor: 4.307

5.  Molecular alterations in primary prostate cancer after androgen ablation therapy.

Authors:  Carolyn J M Best; John W Gillespie; Yajun Yi; Gadisetti V R Chandramouli; Mark A Perlmutter; Yvonne Gathright; Heidi S Erickson; Lauren Georgevich; Michael A Tangrea; Paul H Duray; Sergio González; Alfredo Velasco; W Marston Linehan; Robert J Matusik; Douglas K Price; William D Figg; Michael R Emmert-Buck; Rodrigo F Chuaqui
Journal:  Clin Cancer Res       Date:  2005-10-01       Impact factor: 12.531

6.  Myocilin regulates cell proliferation and survival.

Authors:  Myung Kuk Joe; Heung Sun Kwon; Radu Cojocaru; Stanislav I Tomarev
Journal:  J Biol Chem       Date:  2014-02-22       Impact factor: 5.157

7.  Identification of a structural motif in the tumor-suppressive protein GRIM-19 required for its antitumor activity.

Authors:  Shreeram C Nallar; Sudhakar Kalakonda; Peng Sun; Yoshihiro Ohmori; Miki Hiroi; Kazumasa Mori; Daniel J Lindner; Dhananjaya V Kalvakolanu
Journal:  Am J Pathol       Date:  2010-07-01       Impact factor: 4.307

8.  Olfactomedin 4 inhibits cathepsin C-mediated protease activities, thereby modulating neutrophil killing of Staphylococcus aureus and Escherichia coli in mice.

Authors:  Wenli Liu; Ming Yan; Yueqin Liu; Kenneth R McLeish; William G Coleman; Griffin P Rodgers
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

9.  Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels.

Authors:  Sudhakar Kalakonda; Shreeram C Nallar; Ping Gong; Daniel J Lindner; Simeon E Goldblum; Sekhar P Reddy; Dhananjaya V Kalvakolanu
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

10.  Gene expression changes associated with resistance to intravenous corticosteroid therapy in children with severe ulcerative colitis.

Authors:  Boyko Kabakchiev; Dan Turner; Jeffrey Hyams; David Mack; Neal Leleiko; Wallace Crandall; James Markowitz; Anthony R Otley; Wei Xu; Pingzhao Hu; Anne M Griffiths; Mark S Silverberg
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.